What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Pathology
His primary scientific interests are in Receptor, Scavenger receptor, Cell biology, Biochemistry and Lipoprotein.
His Receptor study is concerned with the field of Internal medicine as a whole.
His work in Scavenger receptor tackles topics such as Foam cell which are related to areas like Downregulation and upregulation, Pathology, Cholesteryl ester and Thoracic aorta.
The concepts of his Cell biology study are interwoven with issues in CXCL2, CCL21, XCL2, C-C chemokine receptor type 6 and CXCL16.
His studies in Biochemistry integrate themes in fields like Molecular biology and Cell adhesion molecule.
His Lipoprotein research integrates issues from CD36, Vascular disease, Coronary atherosclerosis and Ischemia.
His most cited work include:
- Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia (806 citations)
- Expression of Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 in Human Atherosclerotic Lesions (379 citations)
- Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells (351 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Endocrinology, Receptor, Cell biology and Cardiology.
His research links Statin with Endocrinology.
The Receptor study combines topics in areas such as Immunology and Oxidized ldl, Lipoprotein, Scavenger receptor.
His study in the field of LDL receptor also crosses realms of Phosphatidylserine.
Foam cell is closely connected to Downregulation and upregulation in his research, which is encompassed under the umbrella topic of Cell biology.
The various areas that he examines in his Cardiology study include Lectin and OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1.
He most often published in these fields:
- Internal medicine (45.33%)
- Endocrinology (28.04%)
- Receptor (24.77%)
What were the highlights of his more recent work (between 2008-2021)?
- Internal medicine (45.33%)
- Cardiology (15.89%)
- Endocrinology (28.04%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Cardiology, Endocrinology, Acute coronary syndrome and Biomarker.
In the field of Internal medicine, his study on Troponin T, Lipoprotein and Matrix metalloproteinase 9 overlaps with subjects such as In patient.
The study incorporates disciplines such as Statin and Steatohepatitis in addition to Endocrinology.
His studies deal with areas such as Receptor, High Sensitivity Troponin T and Percutaneous coronary intervention as well as Acute coronary syndrome.
His Receptor research focuses on Angiotensin II in particular.
His Biomarker research focuses on subjects like Pathology, which are linked to Artery and Thrombus.
Between 2008 and 2021, his most popular works were:
- MicroRNA-33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE−/− Mice (167 citations)
- MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice (140 citations)
- Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome--a pilot study. (48 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Pathology
Noriaki Kume focuses on Internal medicine, Biomarker, Troponin T, Acute coronary syndrome and Cardiology.
His research in Internal medicine intersects with topics in Endocrinology and RHOA.
His Endocrinology study combines topics from a wide range of disciplines, such as Pitavastatin, Apolipoprotein E and Bone marrow.
His Biomarker study combines topics in areas such as Immunology and Lipoprotein.
His Acute coronary syndrome research is multidisciplinary, incorporating perspectives in Gastroenterology, Area under the curve and Optical coherence tomography.
His research integrates issues of Diagnostic marker and Pathology in his study of Cardiology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
